Four biotechs emerge with $800M and in-li­censed as­sets on Fri­day

Four new biotechs launched Fri­day with megarounds and in-li­censed treat­ment can­di­dates, giv­ing the in­dus­try an $800 mil­lion boost ahead of the year’s biggest deal­mak­ing event …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER